Teleflex FY2024 EPS Estimate Decreased by Zacks Research

Teleflex Incorporated (NYSE:TFX) – Research analysts at Zacks Research decreased their FY2024 EPS estimates for Teleflex in a research note issued on Wednesday, January 8th. Zacks Research analyst R. Department now anticipates that the medical technology company will post earnings per share of $13.95 for the year, down from their previous estimate of $13.97. The consensus estimate for Teleflex’s current full-year earnings is $13.98 per share. Zacks Research also issued estimates for Teleflex’s Q1 2025 earnings at $3.51 EPS, Q1 2026 earnings at $4.14 EPS, Q2 2026 earnings at $4.16 EPS and Q3 2026 earnings at $4.13 EPS.

Teleflex (NYSE:TFX) last announced its earnings results on Thursday, October 31st. The medical technology company reported $3.49 earnings per share for the quarter, beating the consensus estimate of $3.38 by $0.11. Teleflex had a return on equity of 14.19% and a net margin of 7.85%. The firm had revenue of $764.40 million for the quarter, compared to the consensus estimate of $768.68 million. During the same quarter in the previous year, the business earned $3.64 EPS. The firm’s revenue for the quarter was up 2.4% on a year-over-year basis.

TFX has been the topic of a number of other reports. StockNews.com upgraded shares of Teleflex from a “hold” rating to a “buy” rating in a research report on Thursday, November 28th. Royal Bank of Canada dropped their target price on Teleflex from $275.00 to $245.00 and set an “outperform” rating on the stock in a report on Friday, November 1st. Needham & Company LLC restated a “hold” rating on shares of Teleflex in a research report on Monday, December 16th. Mizuho lowered their price target on Teleflex from $275.00 to $250.00 and set a “neutral” rating on the stock in a research report on Friday, November 1st. Finally, Truist Financial dropped their price objective on Teleflex from $227.00 to $200.00 and set a “hold” rating on the stock in a research note on Wednesday, December 18th. Three research analysts have rated the stock with a hold rating and five have issued a buy rating to the stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus target price of $252.50.

Teleflex Stock Performance

TFX stock opened at $178.84 on Monday. The company has a 50-day simple moving average of $185.76 and a 200 day simple moving average of $216.38. The company has a market capitalization of $8.31 billion, a P/E ratio of 35.55, a PEG ratio of 1.84 and a beta of 1.16. The company has a quick ratio of 1.39, a current ratio of 2.42 and a debt-to-equity ratio of 0.37. Teleflex has a fifty-two week low of $171.69 and a fifty-two week high of $256.85.

Institutional Investors Weigh In On Teleflex

Several hedge funds have recently modified their holdings of the stock. Acadian Asset Management LLC raised its stake in Teleflex by 84.7% during the 2nd quarter. Acadian Asset Management LLC now owns 399 shares of the medical technology company’s stock valued at $83,000 after purchasing an additional 183 shares during the period. Choreo LLC acquired a new position in Teleflex during the second quarter valued at $220,000. Royal London Asset Management Ltd. raised its position in Teleflex by 1.8% during the second quarter. Royal London Asset Management Ltd. now owns 18,809 shares of the medical technology company’s stock valued at $3,956,000 after buying an additional 334 shares during the period. American Century Companies Inc. lifted its stake in Teleflex by 4.6% in the 2nd quarter. American Century Companies Inc. now owns 9,509 shares of the medical technology company’s stock worth $2,000,000 after acquiring an additional 420 shares in the last quarter. Finally, DekaBank Deutsche Girozentrale boosted its position in Teleflex by 1,388.6% during the 2nd quarter. DekaBank Deutsche Girozentrale now owns 108,516 shares of the medical technology company’s stock worth $22,331,000 after acquiring an additional 101,226 shares during the period. 95.62% of the stock is owned by hedge funds and other institutional investors.

Teleflex Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Monday, December 16th. Shareholders of record on Friday, November 15th were issued a $0.34 dividend. The ex-dividend date of this dividend was Friday, November 15th. This represents a $1.36 annualized dividend and a dividend yield of 0.76%. Teleflex’s dividend payout ratio is currently 27.04%.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.